Risultati della ricerca - "DNDi"

Drug discovery and development for neglected diseases: the DNDi model di Eric Chatelain, Jean-Robert Ioset

Connect to this object online.

Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis di Katrien Van Bocxlaer, Kerri-Nicola McArthur, Andy Harris, Mo Alavijeh, Stéphanie Braillard, Charles E. Mowbray, Simon L. Croft

Connect to this object online.

Antibacterial and Antibiofilm Properties of the Alexidine Dihydrochloride (MMV396785) against <i>Acinetobacter baumannii</i> di Kirti Upmanyu, Qazi Mohd. Rizwanul Haq, Ruchi Singh

Connect to this object online.

Translational challenges of animal models in Chagas disease drug development: a review di Chatelain E, Konar N

Connect to this object online.

Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis... di María Del Mar Castro, Astrid C Erber, Byron Arana, Gláucia Cota, Claudia M Denkinger, Nicole Harrison, Julia Kutyi, Liliana López-Carvajal, Emma Plugge, Julia Walochnik, Piero Olliaro

Connect to this object online.

Population pharmacokinetics of benznidazole in neonates, infants and children using a new pediatric formulation. di Jaime Altcheh, Guillermo Moscatelli, Martin Caruso, Samanta Moroni, Margarita Bisio, Maria Rosa Miranda, Celia Monla, Maria Vaina, Maria Valdez, Lucrecia Moran, Teresa Ramirez, Oscar Ledesma Patiño, Adelina Riarte, Nicolas Gonzalez, Jayme Fernandes, Fabiana Alves, Isabela Ribeiro, Facundo Garcia-Bournissen

Connect to this object online.

Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh. di Ridwanur Rahman, Vishal Goyal, Rashidul Haque, Kazi Jamil, Abul Faiz, Rasheda Samad, Sally Ellis, Manica Balasegaram, Margriet den Boer, Suman Rijal, Nathalie Strub-Wourgaft, Fabiana Alves, Jorge Alvar, Bhawna Sharma

Connect to this object online.

Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness. di Els Torreele, Bernadette Bourdin Trunz, David Tweats, Marcel Kaiser, Reto Brun, Guy Mazué, Michael A Bray, Bernard Pécoul

Connect to this object online.